Abstract Details
|
Matthew Pase, PhD
(Monash University)
PRESENTER |
Dr. Pase has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheimer's Disease Drug Discovery Foundation. |
| Alexa Beiser | Alexa Beiser has nothing to disclose. |
| Jayandra Himali | Jayandra Himali has nothing to disclose. |
| Claudia L. Satizabal, PhD (UT Health San Antonio) | The institution of Dr. Satizabal has received research support from NIH and TARCC. |
| Hugo Javier Aparicio, MD, MPH (Boston University) | Dr. Aparicio has received research support from Â鶹´«Ã½Ó³». Dr. Aparicio has received research support from Alzheimer's Association. Dr. Aparicio has received research support from National Institutes of Health. Dr. Aparicio has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist for the Memory & Healthy Aging Program with Cedars-Sinai. |
| Charles S. DeCarli, MD, FÂ鶹´«Ã½Ó³» (UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center) | Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH. |
| Sudha Seshadri, MD, FÂ鶹´«Ã½Ó³» (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |